Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sakahlé Condé"'
Autor:
Marie Selvy, Catherine Mattévi, Cristelle Dalbos, Youssef Aissouni, Eric Chapuy, Pierre-Yves Martin, Aurore Collin, Damien Richard, Charles Dumontet, Jérôme Busserolles, Sakahlé Condé, David Balayssac
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112915- (2022)
Background: Donepezil, a cholinesterase inhibitor approved in Alzheimer’s disease, has demonstrated analgesic and preventive effects in animal models of oxaliplatin-induced neuropathy. To improve the clinical interest of donepezil for the managemen
Externí odkaz:
https://doaj.org/article/4a3c89020b1444e2ae268de916d99bee
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Elsevier, 2020, 21, pp.44-48. ⟨10.1016/j.ctro.2020.01.001⟩
Clinical and Translational Radiation Oncology, Vol 21, Iss, Pp 44-48 (2020)
Clinical and Translational Radiation Oncology, 2020, 21, pp.44-48. ⟨10.1016/j.ctro.2020.01.001⟩
Clinical and Translational Radiation Oncology, Elsevier, 2020, 21, pp.44-48. ⟨10.1016/j.ctro.2020.01.001⟩
Clinical and Translational Radiation Oncology, Vol 21, Iss, Pp 44-48 (2020)
Clinical and Translational Radiation Oncology, 2020, 21, pp.44-48. ⟨10.1016/j.ctro.2020.01.001⟩
Highlights • No correlation between radiotherapy and the development of MS is to date described. • Demyelination can occur after radiotherapy in tissue adjacent to irradiated tumours. • MS lesions seem to occur in regions irradiated with a mean
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab7c3355ef86e95b8fb1ce580a17141
https://doi.org/10.1016/j.ctro.2020.01.001
https://doi.org/10.1016/j.ctro.2020.01.001
Autor:
Michel Lauxerois, B. Debilly, Eve Chanson, Sakahlé Condé, Franck Durif, Philippe Derost, Ana Marques
Publikováno v:
Parkinsonism & Related Disorders. 78:68-69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf8457405d5b6c55061e548096b0d68a
https://doi.org/10.1016/j.parkreldis.2020.07.012
https://doi.org/10.1016/j.parkreldis.2020.07.012
Autor:
Michel Lauxerois, Renato Colamarino, Mélissa Zuel, Sakahlé Condé, Pierre Clavelou, M. Maillet‐vioud, Xavier Moisset, Bruno Pereira, F. Taithe
Publikováno v:
European Journal of Neurology
European Journal of Neurology, 2018, 26 (3), pp.460-467. ⟨10.1111/ene.13839⟩
European Journal of Neurology, Wiley, 2018, 26 (3), pp.460-467. ⟨10.1111/ene.13839⟩
European Journal of Neurology, 2018, 26 (3), pp.460-467. ⟨10.1111/ene.13839⟩
European Journal of Neurology, Wiley, 2018, 26 (3), pp.460-467. ⟨10.1111/ene.13839⟩
Background and purpose Dimethyl fumarate (DMF) and teriflunomide are approved oral disease-modifying treatments for relapsing-remitting multiple sclerosis (MS). Phase 3 trials established these agents to be effective and generally well tolerated, alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d14fbf8e0efc4779830bbbff5a09641
https://hal.science/hal-02462218
https://hal.science/hal-02462218
Autor:
Aurore Collin, Sakahlé Condé, David Balayssac, Nicolas Kerckhove, Carine Chaleteix, Denis Pezet
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2017, 8, ⟨10.3389/fphar.2017.00086⟩
Frontiers in Pharmacology, Frontiers, 2017, 8, ⟨10.3389/fphar.2017.00086⟩
Neurotoxic anticancer drugs, such as platinum-based anticancer drugs, taxanes, vinca alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy-induced peripheral neuropathy (CIPN). The health consequences of CIPN remain worry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c85307b2769c12820f1d46d53dc0e5
Autor:
Michel Lauxerois, Pierre Clavelou, Xavier Moisset, Mélissa Zuel, Bruno Pereira, Sakahlé Condé
Publikováno v:
Revue Neurologique. 174:S99
Introduction Depuis trois ans, deux traitements oraux de premiere ligne de la sclerose en plaques recurrente-remittente (SEP-RR), sont disponibles en France : le dimethyl-fumarate (DMF) et le teriflunomide. Objectifs Evaluer l’efficacite et la tole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25af45df98fe48b291ef5cf4a794ee6f
https://doi.org/10.1016/j.neurol.2018.01.223
https://doi.org/10.1016/j.neurol.2018.01.223
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 21, Iss , Pp 44-48 (2020)
Introduction: Demyelination can occur after brain radiotherapy in tissue adjacent to irradiated tumours. To date, no correlation has been found between conventional-dose radiotherapy and the development of multiple sclerosis, but radiotherapy could b
Externí odkaz:
https://doaj.org/article/304cdd205fe54d5a9e27828ef1ebdc46